Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005

British Journal of Cancer

Volumn 100, Issue 5, 2009, Pages 799-802

  Ocama, P ^a   Nambooze, S ^a   Opio, C K ^a   Shiels, M S ^b   Wabinga, H R ^a   Kirk, G D ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Africa; Cancer registry; Gender differences; Hepatocellular carcinoma; Human immunodeficiency virus acquired immunodeficiency syndrome (HIV AIDS); Primary liver cancer

Indexed keywords

AFLATOXIN; ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; ECHOGRAPHY; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; OBESITY; PRIMARY TUMOR; PRIORITY JOURNAL; SEX DIFFERENCE; TREND STUDY; UGANDA; VIRUS HEPATITIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS; UGANDA;

EID: 61749100892     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604893     Document Type: Article

References (45)

1. Alpert ME, Hutt MS, Wogan GN, Davidson CS (1971) Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer 28: 253-260
2. Bah E, Parkin DM, Hall AJ, Jack AD, Whittle H (2001) Cancer in the Gambia: 1988-97. Br J Cancer 84: 1207-1214
3. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, Snydman DR (2001) Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32: 492-497
4. Biggar RJ, Ortiz-Conde BA, Bagni RK, Bakaki PM, Wang CD, Engels EA, Mbulaiteye SM, Ndugwa CM (2006) Hepatitis C virus genotype 4 in Ugandan children and their mothers. Emerg Infect Dis 12: 1440-1443
5. Boyle P, Parkin DM (1991) Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ 95: 126-158
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638
7. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336: 1855-1859
8. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97: 425-432
9. Cooke A (1998) CANREG3 Manual. Internal Report No. 98/03. International Agency for Research on Cancer: Lyon
10. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127: 1372-1380
11. de Lalla F, Rizzardini G, Rinaldi E, Santoro D, Zeli PL, Verga G (1990) HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas. Trans R Soc Trop Med Hyg 84: 144-147
12. El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127: S27-S34
13. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126: 460-468
14. Goh KT (1997) Prevention and control of hepatitis B virus infection in Singapore. Ann Acad Med Singapore 26: 671-681
15. Gondos A, Brenner H, Wabinga H, Parkin DM (2005) Cancer survival in Kampala, Uganda. Br J Cancer 92: 1808-1812
16. Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R (2006) Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 11: 951-954
17. Ho SKW, Johnson PJ (1999) Tumor markers. In Hepatocellular Carcinoma: Contemporary Diagnosis, Investigation and Management, Leong AS-Y, Liew CT, Lau JWY, Johnson PJ (eds), pp 31-41. Oxford University Press Inc.: New York, NY
18. Jackson JB, Guay L, Goldfarb J, Olness K, Ndugwa C, Mmiro F, Kataaha P, Allain JP (1991) Hepatitis C virus antibody in HIV-1 infected Ugandan mothers. Lancet 337: 551
19. Kaaya AN, Kyamuhangire W (2006) The effect of storage time and agroecological zone on mould incidence and aflatoxin contamination of maize from traders in Uganda. Int J Food Microbiol 110: 217-223
20. Kew MC, Rossouw E, Hodkinson J, Paterson A, Dusheiko GM, Whitcutt JM (1983) Hepatitis B virus status of southern African Blacks with hepatocellular carcinoma: comparison between rural and urban patients. Hepatology 3: 65-68
21. Kimbi GC, Kew MC, Yu MC, Arakawa K, Hodkinson J (2005) 249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma. J Gastroenterol Hepatol 20: 1185-1190
22. Kirk GD, Bah E, Montesano R (2006) Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis 27: 2070-2082
23. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, Hainaut P, Hall AJ, Whittle H, Montesano R (2004) The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39: 211-219
24. Kramer JR, Giordano TP, Souchek J, Richardson P, Hwang LY, El-Serag HB (2005) The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C. Am J Gastroenterol 100: 56-63
25. Larsson SC, Wolk A (2007) Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 97: 1005-1008
26. Lasky D, Becerra E, Boto W, Otim M, Ntambi J (2002) Obesity and gender differences in the risk of type 2 diabetes mellitus in Uganda. Nutrition 18: 417-421
27. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118: 985-990
28. Mbulaiteye SM, Parkin DM, Rabkin CS (2003) Epidemiology of AIDS-related malignancies: an international perspective. Hematol Oncol Clin North Am 17: 673-696
29. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni Jr JF (2001) International trends and patterns of primary liver cancer. Int J Cancer 94: 290-296
30. Ministry of Health (MOH) (Uganda), ORC Macro (2006) Uganda HIV/AIDS Sero-behavioural Survey 2004-2005. Ministry of Health and ORC Macro: Calverton, MD, USA
31. Nakwagala FN, Kagimu MM (2002) Hepatitis B virus and HIV infections among patients in Mulago hospital. East Afr Med J 79: 68-72
32. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044
33. Parkin DM, Wabinga H, Nambooze S (2001) Completeness in an African cancer registry. Cancer Causes Control 12: 147-152
34. Percy C, Van Holten V, Muir C (eds) (1990) International Classification of Diseases for Oncology. World Health Organization: Geneva, Switzerland
35. Pido B, Kagimu M (2005) Prevalence of hepatitis B virus (HBV) infection among Makerere University medical students. Afr Health Sci 5: 93-98
36. Powles T, Macdonald D, Nelson M, Stebbing J (2006) Hepatocellular cancer in HIV-infected individuals: tomorrow's problem? Expert Rev Anticancer Ther 6: 1553-1558
37. Sadikali F (1972) Hepatitis-associated antigen and acute and chronic liver disease in Uganda. East Afr Med J 49: 783-790
38. Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet F, Heripret L, Costagliola D, May T, Chene G (2005) Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol 42: 799-805
39. Tabor E, Gerety RJ, Vogel CL, Bayley AC, Anthony PP, Chan CH, Barker LF (1977) Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst 58: 1197-1200
40. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC (1997) Increase in primary liver cancer in the UK, 1979-94. Lancet 350: 1142-1143
41. US Census Bureau (2007) World Population Information: Population by Age and Sex US Ceusus Bureau. http://www.census.gov/ipc/www/idb/ worldpopinfo.html Accessed 1 December 2007
42. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S (2000) Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 82: 1585-1592
43. West J, Wood H, Logan RF, Quinn M, Aithal GP (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 94: 1751-1758
44. WHO (2004) Global Status Report on Alcohol 2004. World Health Organization: Geneva
45. Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ (2003) Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology 38: 1393-1400